Evidence-based therapy for heart failure

Heart failure (HF) is a major public health problem associated with increased morbidity and mortality. As the US life expectancy increases and the population ages, the overall prevalence of HF will continue to escalate. The increasing use of effective selective therapies such as neurohormonal blocka...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Medical clinics of North America Jg. 96; H. 5; S. 915
Hauptverfasser: Deedwania, Prakash C, Carbajal, Enrique
Format: Journal Article
Sprache:Englisch
Veröffentlicht: United States 01.09.2012
Schlagworte:
Adrenergic beta-Antagonists - therapeutic use
Angiotensin-Converting Enzyme Inhibitors - therapeutic use
Evidence-Based Medicine
Heart Failure - drug therapy
Heart Failure - physiopathology
Hospitalization
Humans
Renin-Angiotensin System - drug effects
Renin-Angiotensin System - physiology
Vasodilator Agents - therapeutic use
Ventricular Dysfunction, Left - drug therapy
ISSN:1557-9859, 1557-9859
Online-Zugang:Weitere Angaben
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Heart failure (HF) is a major public health problem associated with increased morbidity and mortality. As the US life expectancy increases and the population ages, the overall prevalence of HF will continue to escalate. The increasing use of effective selective therapies such as neurohormonal blockade in the treatment of patients with HF has led to considerable improvement in their prognosis. During the past several decades, some studies have demonstrated the benefits of treatment; based on the evidence available from these studies, various national and international guidelines have specific recommendations for the evidence-based therapy with these drugs in patients with HF.
Bibliographie:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
ISSN:1557-9859
1557-9859
DOI:10.1016/j.mcna.2012.07.010